메뉴 건너뛰기




Volumn 7, Issue 6, 2014, Pages 953-959

Elevation in high-sensitivity troponin t in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696

Author keywords

Heart failure; Neprilysin; Troponin T

Indexed keywords

3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONIC ACID PLUS VALSARTAN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; VALSARTAN; 3-(1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-3'-METHYL-2'-(PENTANOYL(2'-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE; AMINOBUTYRIC ACID DERIVATIVE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; MEMBRANE METALLOENDOPEPTIDASE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TETRAZOLE DERIVATIVE; VALINE;

EID: 84920171497     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001427     Document Type: Article
Times cited : (83)

References (28)
  • 2
    • 84866400461 scopus 로고    scopus 로고
    • Troponin elevation in patients with heart failure: On behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
    • Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265-2271.
    • (2012) Eur Heart J. , vol.33 , pp. 2265-2271
    • Januzzi, J.L.1    Filippatos, G.2    Nieminen, M.3    Gheorghiade, M.4
  • 5
    • 7044233456 scopus 로고    scopus 로고
    • Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction
    • Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest. 2004;64:667-676.
    • (2004) Scand J Clin Lab Invest. , vol.64 , pp. 667-676
    • Löwbeer, C.1    Gustafsson, S.A.2    Seeberger, A.3    Bouvier, F.4    Hulting, J.5
  • 6
    • 84896141366 scopus 로고    scopus 로고
    • Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: Results from the CORONA trial
    • CORONA Study Group
    • Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail. 2014;7:96-103.
    • (2014) Circ Heart Fail. , vol.7 , pp. 96-103
    • Gravning, J.1    Askevold, E.T.2    Nymo, S.H.3    Ueland, T.4    Wikstrand, J.5    McMurray, J.J.6    Aukrust, P.7    Gullestad, L.8    Kjekshus, J.9
  • 7
    • 84856106687 scopus 로고    scopus 로고
    • Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: Data from 2 large randomized clinical trials
    • Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Investigators
    • Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Investigators. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation. 2012;125:280-288.
    • (2012) Circulation. , vol.125 , pp. 280-288
    • Masson, S.1    Anand, I.2    Favero, C.3    Barlera, S.4    Vago, T.5    Bertocchi, F.6    Maggioni, A.P.7    Tavazzi, L.8    Tognoni, G.9    Cohn, J.N.10    Latini, R.11
  • 8
    • 84868589495 scopus 로고    scopus 로고
    • Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: A report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study
    • Perna ER, Aspromonte N, Cimbaro Canella JP, Di Tano G, Macin SM, Feola M, Coronel ML, Milani L, Parras JI, Milli M, García EH, Valle R. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study. J Card Fail. 2012;18:822-830.
    • (2012) J Card Fail. , vol.18 , pp. 822-830
    • Perna, E.R.1    Aspromonte, N.2    Cimbaro Canella, J.P.3    Di Tano, G.4    Macin, S.M.5    Feola, M.6    Coronel, M.L.7    Milani, L.8    Parras, J.I.9    Milli, M.10    García, E.H.11    Valle, R.12
  • 10
    • 69049107557 scopus 로고    scopus 로고
    • Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function
    • Shah RV, Chen-Tournoux AA, Picard MH, Januzzi JL. Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr. 2009;10:765-768.
    • (2009) Eur J Echocardiogr. , vol.10 , pp. 765-768
    • Shah, R.V.1    Chen-Tournoux, A.A.2    Picard, M.H.3    Januzzi, J.L.4
  • 11
    • 3843094224 scopus 로고    scopus 로고
    • Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle
    • Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953-1959.
    • (2004) N Engl J Med. , vol.350 , pp. 1953-1959
    • Zile, M.R.1    Baicu, C.F.2    Gaasch, W.H.3
  • 12
    • 83155192115 scopus 로고    scopus 로고
    • Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction
    • I-PRESERVE Investigators
    • Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE; I-PRESERVE Investigators. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501.
    • (2011) Circulation. , vol.124 , pp. 2491-2501
    • Zile, M.R.1    Gottdiener, J.S.2    Hetzel, S.J.3    McMurray, J.J.4    Komajda, M.5    McKelvie, R.6    Baicu, C.F.7    Massie, B.M.8    Carson, P.E.9
  • 14
    • 84867745957 scopus 로고    scopus 로고
    • The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
    • Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators
    • Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012;380:1387-1395.
    • (2012) Lancet. , vol.380 , pp. 1387-1395
    • Solomon, S.D.1    Zile, M.2    Pieske, B.3    Voors, A.4    Shah, A.5    Kraigher-Krainer, E.6    Shi, V.7    Bransford, T.8    Takeuchi, M.9    Gong, J.10    Lefkowitz, M.11    Packer, M.12    McMurray, J.J.13
  • 16
    • 29244432482 scopus 로고    scopus 로고
    • Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
    • Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography
    • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
    • (2005) J Am Soc Echocardiogr. , vol.18 , pp. 1440-1463
    • Lang, R.M.1    Bierig, M.2    Devereux, R.B.3    Flachskampf, F.A.4    Foster, E.5    Pellikka, P.A.6    Picard, M.H.7    Roman, M.J.8    Seward, J.9    Shanewise, J.S.10    Solomon, S.D.11    Spencer, K.T.12    Sutton, M.S.13    Stewart, W.J.14
  • 17
    • 35348837803 scopus 로고    scopus 로고
    • B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart
    • Burley DS, Baxter GF. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol. 2007;102:529-541.
    • (2007) Basic Res Cardiol. , vol.102 , pp. 529-541
    • Burley, D.S.1    Baxter, G.F.2
  • 21
    • 84870556584 scopus 로고    scopus 로고
    • What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?
    • Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol. 2012;60:2349-2356.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2349-2356
    • Campbell, R.T.1    Jhund, P.S.2    Castagno, D.3    Hawkins, N.M.4    Petrie, M.C.5    McMurray, J.J.6
  • 23
    • 0037423671 scopus 로고    scopus 로고
    • Myocyte death, growth, and regeneration in cardiac hypertrophy and failure
    • Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003;92:139-150.
    • (2003) Circ Res. , vol.92 , pp. 139-150
    • Nadal-Ginard, B.1    Kajstura, J.2    Leri, A.3    Anversa, P.4
  • 25
    • 84886644443 scopus 로고    scopus 로고
    • Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
    • Kawasaki T, Sakai C, Harimoto K, Yamano M, Miki S, Kamitani T. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013;112:867-872.
    • (2013) Am J Cardiol. , vol.112 , pp. 867-872
    • Kawasaki, T.1    Sakai, C.2    Harimoto, K.3    Yamano, M.4    Miki, S.5    Kamitani, T.6
  • 27
    • 79952829685 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment
    • Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670-679.
    • (2011) Eur Heart J. , vol.32 , pp. 670-679
    • Borlaug, B.A.1    Paulus, W.J.2
  • 28
    • 84901983713 scopus 로고    scopus 로고
    • Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: An analysis of the PARAMOUNT trial
    • Jhund PS, Claggett B, Packer M, Zile MR, Voors AA, Pieske B, Lefkowitz M, Shi V, Bransford T, McMurray JJ, Solomon SD. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. Eur J Heart Fail. 2014;16:671-677.
    • (2014) Eur J Heart Fail. , vol.16 , pp. 671-677
    • Jhund, P.S.1    Claggett, B.2    Packer, M.3    Zile, M.R.4    Voors, A.A.5    Pieske, B.6    Lefkowitz, M.7    Shi, V.8    Bransford, T.9    McMurray, J.J.10    Solomon, S.D.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.